# Muscle, Neuromuscular, and Cardiac Damage in Trail Running: A Systematic Review

**Authors:** Isabel García-Valiente, Francisco Pradas, Miguel Ángel Ortega-Zayas, Carlos Castellar-Otín, Alejandro García-Giménez, Miguel Lecina

PMC · DOI: 10.3390/muscles5010009 · Muscles · 2026-01-29

## TL;DR

This review finds that trail running causes acute muscle, neuromuscular, and cardiac stress, which is mostly reversible.

## Contribution

The study systematically reviews the acute physiological effects of trail running on muscle, neuromuscular, and cardiac systems.

## Key findings

- Trail running increases muscle damage biomarkers like creatine kinase and alanine aminotransferase.
- Neuromuscular performance declines significantly after trail running events.
- Cardiac biomarkers show transient elevations, indicating acute but reversible cardiac stress.

## Abstract

Background: Trail running (TR) is an endurance discipline characterized by prolonged exercise, irregular terrain, and marked elevation changes, which increase eccentric muscular load and may induce muscular, neuromuscular, and cardiac damage. Objective: This study aimed to systematically review the evidence on muscular, neuromuscular, and cardiac damage associated with TR participation. Methods: This systematic review followed PRISMA 2020 guidelines and was registered in PROSPERO (CRD420251135043). Five databases (PubMed, Web of Science, Scopus, SportDiscus, and ScienceDirect) were searched up to 31 August 2025. Observational, longitudinal, prospective, and case studies involving healthy adolescent or adult trail runners were included. Outcomes comprised muscle damage biomarkers (e.g., creatine kinase, alanine aminotransferase), neuromuscular function (e.g., squat jump performance, maximal voluntary isometric contraction), and cardiac biomarkers (e.g., CK-MB, cardiac troponins, NT-proBNP). Methodological quality was assessed using the National Heart, Lung, and Blood Institute Study Quality Assessment Tool. Results were synthesized qualitatively. Results: Fifteen studies met the inclusion criteria, including a total of 247 participants. Post-race analyses consistently showed marked increases in muscle damage biomarkers and significant reductions in neuromuscular performance. Transient elevations in cardiac biomarkers were also observed, suggesting acute but reversible cardiac stress following TR events. Limitations: Evidence was limited by methodological heterogeneity, small sample sizes, and underrepresentation of female athletes. Conclusions: It was found that trail running induces substantial acute muscular, neuromuscular, and cardiac stress, particularly in events with high eccentric loading. Monitoring biochemical and neuromuscular markers may support training load optimization, recovery strategies, and injury prevention.

## Linked entities

- **Proteins:** ckmb (creatine kinase, muscle b)

## Full-text entities

- **Genes:** GPT (glutamic--pyruvic transaminase) [NCBI Gene 2875] {aka AAT1, ALT, ALT1, GPT1, SGPT}, CMPK1 (cytidine/uridine monophosphate kinase 1) [NCBI Gene 51727] {aka CK, CMK, CMPK, UMK, UMP-CMPK, UMPK}, MB (myoglobin) [NCBI Gene 4151] {aka MYOSB, PVALB}, TNNI3 (troponin I3, cardiac type) [NCBI Gene 7137] {aka CMD1FF, CMD2A, CMH7, RCM1, TNNC1, cTnI}, SLC17A5 (solute carrier family 17 member 5) [NCBI Gene 26503] {aka AST, ISSD, NSD, SD, SIALIN, SIASD}, NPPB (natriuretic peptide B) [NCBI Gene 4879] {aka BNP, Iso-ANP}, F2R (coagulation factor II thrombin receptor) [NCBI Gene 2149] {aka CF2R, HTR, PAR-1, PAR1, TR}
- **Diseases:** accidents (MESH:D000081084), cardiac strain (MESH:D013180), Cardiac Damage (MESH:D006331), myocardial damage (MESH:D009202), Neuromuscular Fatigue (MESH:D005221), muscle injury (MESH:D009135), structural (MESH:D020914), heart failure (MESH:D006333), ankle sprains (MESH:D016512), falls (MESH:C537863), musculoskeletal injuries (MESH:D009140), neuromuscular function (MESH:D020879), Neuromuscular, and (MESH:D009468), acute fatigue (MESH:D000208), muscle fiber damage (MESH:C563545), stress fractures (MESH:D015775), MVIC (MESH:D009155), Muscle, (MESH:D019042), impaired force production (MESH:D007787), HT (MESH:D006973), Achilles and patellar tendinopathies (MESH:D052256), muscular overload (MESH:D019190), rhabdomyolysis (MESH:D012206), Injury (MESH:D014947), knee injuries (MESH:D007718), inflammation (MESH:D007249), Muscle Damage (MESH:D009133), dehydration (MESH:D003681), TR (MESH:D020195), myocardial infarction (MESH:D009203)
- **Chemicals:** oxygen (MESH:D010100), N-terminal pro-brain natriuretic peptide (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** M11 F

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12921809/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12921809/full.md

## References

76 references — full list in the complete paper: https://tomesphere.com/paper/PMC12921809/full.md

---
Source: https://tomesphere.com/paper/PMC12921809